Issue of Equity

RNS Number : 4384D
Amati AIM VCT PLC
02 March 2022
 

Amati AIM VCT plc

 

2 March 2022

 

Amati AIM VCT plc (the "Company")

 

Legal Entity Identifier: 213800HAEDBBK9RWCD25

 

Issue of Equity

 

The Board of Amati AIM VCT plc (the "Company") is pleased to announce that on 2 March 2022 it allotted 11,429,326 new Ordinary Shares of 5p each in the capital of the Company ("Ordinary Shares") pursuant to the re-opening of the Offer for Subscription on 16 February 2022 (the "Offer"). In accordance with the terms and conditions of the Offer, the price at which new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an ordinary share on 28 February 2022, was 166.42p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%).

 

As announced on 21 February 2022, the Offer is fully subscribed and closed for further applications.

 

Applications have been made for the new Ordinary Shares to be admitted to the Official List of the FCA (with a Premium Listing) and to the London Stock Exchange for admission to trading on the main market for listed securities. It is expected that admission will occur and dealing will commence in the new Ordinary Shares on or around 10 March 2022.

 

As a result of the issue, the total number of Ordinary Shares in issue will be 147,999,507 and the total number of voting rights in the Company will be 147,999,507. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

 

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at  info@amatiglobal.com .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBKBBPABKDQNK
UK 100

Latest directors dealings